Wolf haldenstein adler freeman & herz llp announces that it is investigating siga technologies, inc. for potential violations of federal securities laws

New york , oct. 23, 2024 /prnewswire/ --  wolf haldenstein adler freeman & herz llp ("wolf haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of siga technologies, inc.(nasdaq: siga) ("siga" or the "company") siga technologies, inc. operates as a commercial-stage pharmaceutical company. the company offers oral formulation of an antiviral drug for the treatment of human smallpox disease caused by variola virus.
SIGA Ratings Summary
SIGA Quant Ranking